EUVIMEDEUVIMED entdecken
Crossref

Copper-induced suppression of the PPARα–FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease

Yingjie Li, Yaoyi Wu, Yanwen Zhou, Liyan Zhao, Zhenyu Xu, Yimin Zhang, Ning Zhou

Journal of Molecular Medicine · 2026

DOI: 10.1007/s00109-026-02725-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2026. Verfasst von Yingjie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: PPAR alpha, Fatty Acid-Binding Proteins, Hepatocytes, Ferroptosis. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wilson disease (WD) is characterized by hepatic copper accumulation and progressive liver injury, yet the mechanisms linking copper overload to hepatocellular damage remain incompletely understood. Here, we identify suppression of the PPARα–FABP1 axis as a key metabolic vulnerability that sensitizes hepatocytes to ferroptosis in WD. Liver tissues from WD patients and Atp7b ^ ⁻/⁻ mice exhibited impaired antioxidant capacity, enhanced lipid peroxidation, and coordinated downregulation of PPARα–FABP1 signaling at both transcriptomic and proteomic levels. In hepatocytes, copper exposure increased nuclear-enriched copper and caused a time-dependent repression of PPARα and FABP1, lowered the threshold for RSL3-induced ferroptotic cell death, and enhanced lipid peroxidation. These effects were mimicked by silencing either PPARα or FABP1 and were partially rescued by ferroptosis inhibition. Integration of published lipidomic datasets revealed accumulation of peroxidized polyunsaturated fatty acids in WD, while FABP1 overexpression mitigated arachidonic acid–driven lipid peroxidation and ferroptosis. Clinically, hepatic expression and circulating levels of FABP1 declined with disease severity and were associated with inflammatory activity and fibrosis stage in WD patients, showing moderate predictive value for adverse outcomes. Together, these findings establish copper-induced suppression of the PPARα–FABP1 axis as a mechanistic link between metabolic dysregulation and ferroptosis in WD, highlighting a potential therapeutic vulnerability in copper-associated liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaFatty Acid-Binding ProteinsHepatocytesFerroptosisCopperHepatolenticular DegenerationAnimalsHumansMiceLipid PeroxidationSignal TransductionLiverMaleMice, Knockout

Stichwörter der Autor:innen

Copper overloadFerroptosisLipid peroxidationPPARα–FABP1 axisWilson disease

Substanzen

PPAR alphaFatty Acid-Binding ProteinsCopperFabp1 protein, mouseFABP1 protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
  • Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China. zhouning1@csu.edu.cn.

Zitieren

APA

Li, Y., Wu, Y., Zhou, Y., Zhao, L., Xu, Z., Zhang, Y., & Zhou, N. (2026). Copper-induced suppression of the PPARα–FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-026-02725-2

Vancouver

Li Y, Wu Y, Zhou Y, Zhao L, Xu Z, Zhang Y, et al. Copper-induced suppression of the PPARα–FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease. Journal of Molecular Medicine. 2026. doi:10.1007/s00109-026-02725-2

BibTeX
@article{Li2026,
  author = {Li, Yingjie and Wu, Yaoyi and Zhou, Yanwen and Zhao, Liyan and Xu, Zhenyu and Zhang, Yimin and Zhou, Ning},
  title = {Copper-induced suppression of the PPARα–FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease},
  journal = {Journal of Molecular Medicine},
  year = {2026},
  doi = {10.1007/s00109-026-02725-2}
}
Kostenlos starten →